Schizophrenia Studies

Recently-diagnosed schizophrenia (Age 18-35)

The study will compare and evaluate the effectiveness of existing medications in people who have recently begun experiencing psychosis.

Treatment-resistant schizophrenia (Age 18+)

The purpose of this trial is to determine if a study drug more effectively relieves schizophrenia symptoms compared to existing medications.